Feinberg to advise new biotech startup

Biolife4D, a new biotech startup, will soon begin finalizing the process of 3-D printing human hearts for transplant. Advised by the original researchers in the field, including MSE/BME’s Adam Feinberg, the startup team will use patients’ own cells to make fully functioning hearts that are the exact size and shape of a patient’s original heart. Because the 3-D printed heart is an exact replica, and because it’s created from the patient’s own cells, it will most likely be more successful than a traditional transplant. The startup was featured in an article for Fast Company.